Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Rating) saw an uptick in trading volume on Wednesday . 14,273 shares were traded during trading, a decline of 62% from the previous session's volume of 37,116 shares.The stock last traded at $152.04 and had previously closed at $150.54.
First Trust NYSE Arca Biotechnology Index Fund Stock Up 1.1 %
The firm's 50-day moving average price is $157.13 and its 200 day moving average price is $150.64. The firm has a market cap of $1.45 billion, a P/E ratio of 16.29 and a beta of 0.82.
Get
First Trust NYSE Arca Biotechnology Index Fund alerts:
Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Several institutional investors have recently bought and sold shares of the stock. Wade G W & Inc. lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.8% in the fourth quarter. Wade G W & Inc. now owns 5,731 shares of the company's stock worth $883,000 after purchasing an additional 100 shares during the period. Moors & Cabot Inc. lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.6% in the 3rd quarter. Moors & Cabot Inc. now owns 7,065 shares of the company's stock valued at $932,000 after acquiring an additional 109 shares during the last quarter. American Financial Advisors LLC lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 2.9% in the 4th quarter. American Financial Advisors LLC now owns 3,815 shares of the company's stock valued at $588,000 after acquiring an additional 109 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 21.4% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 699 shares of the company's stock valued at $108,000 after acquiring an additional 123 shares during the last quarter. Finally, Financial Enhancement Group LLC lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 4.1% in the 3rd quarter. Financial Enhancement Group LLC now owns 3,760 shares of the company's stock valued at $496,000 after acquiring an additional 147 shares during the last quarter.
About First Trust NYSE Arca Biotechnology Index Fund
(Get Rating)
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Articles
- Get a free copy of the StockNews.com research report on First Trust NYSE Arca Biotechnology Index Fund (FBT)
- Three Mid Caps Wall Street Sees Doubling Within 12 Months
- It's No Stretch: Lululemon Could Break Out of its Range
- Visa: Turnkey Investment to Finance Inflation-Tightened Wallets
- Three Pullback Opportunities in Tech Right Now
- Micron Technology Goes on Breakout Watch
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
First Trust NYSE Arca Biotech Index Fund(NYSEARCA：FBT-GET评级)的股票周三成交量上升。当日成交量为14,273股，较前一交易日的37,116股减少了62%。该股最新报152.04美元，此前收盘价为150.54美元。
First Trust NYSE Arca生物技术指数基金上涨1.1%
该公司的50日移动均线价格为157.13美元，200日移动均线价格为150.64美元。该公司市值为14.5亿美元，市盈率为16.29倍，贝塔系数为0.82。
到达
First Trust NYSE Arca生物技术指数基金警报：
机构投资者看好First Trust NYSE Arca生物技术指数基金
几家机构投资者最近买卖了该股的股票。Wade G W&Inc.在第四季度增持了First Trust NYSE Arca Biotech Index Fund 1.8%的股份。Wade G W&Inc.在此期间又购买了100股，现在持有5,731股该公司股票，价值883,000美元。Moors&Cabot Inc.在第三季度增持了First Trust NYSE Arca Biotech Index Fund 1.6%的股份。Moors&Cabot Inc.目前持有7,065股该公司股票，价值93.2万美元，此前该公司在上个季度增持了109股。American Financial Advisors LLC在第四季度将其在First Trust NYSE Arca Biotech Index Fund的持有量增加了2.9%。American Financial Advisors LLC现在拥有3815股该公司股票，价值58.8万美元，在上个季度增持了109股。苏黎世广东银行在第四季度增持了First Trust NYSE Arca Biotech Index Fund 21.4%的股份。Zurcher Kantonalbank苏黎世广东银行在上个季度额外收购了123股后，现在拥有699股该公司股票，价值10.8万美元。最后，金融增强集团有限责任公司在第三季度增持了First Trust NYSE Arca Biotech Index Fund 4.1%的股份。金融增强集团有限责任公司现在拥有3760股该公司的股票，价值49.6万美元，在上个季度额外购买了147股。
关于First Trust NYSE Arca生物技术指数基金
(获取评级)
First Trust NYSE Arca Biotech Index Fund(FBT)是一只基于NYSE Arca生物技术指数的交易所交易基金。该基金追踪美国生物科技股的一个同等权重指数。FBT成立于2006年6月19日，由First Trust管理。
专题文章
- 免费获取StockNews.com关于First Trust NYSE Arca生物技术指数基金(FBT)的研究报告
- 华尔街预计三只中型股在12个月内翻一番
- 这是不可伸展的：lululemon可以突破它的范围
- Visa：交钥匙投资为通胀收紧的钱包提供资金
- 眼下科技行业的三个回调机会
- 美光科技进入突破口观察
获得First Trust纽约证交所Arca生物技术指数基金每日新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对First Trust NYSE Arca Biotech Index Fund和相关公司的最新新闻和分析师评级的每日简要摘要。
